<DOC>
	<DOCNO>NCT00980083</DOCNO>
	<brief_summary>Synthetic GLP-1 lower postprandial ( pp ) glycemia stimulate insulin , inhibit glucagon , delay gastric emptying . However , effect endogenous peptide largely unknown . Using specific GLP-1 receptor antagonist exendin ( 9-39 ) amide ( Ex ( 9-39 ) ) investigator recently show GLP-1 release intestinal meal perfusion act incretin hormone enterogastrone . As relative contribution effect controll postprandial glycemia unclear , investigator use Ex ( 9-39 ) investigate mechanisms action GLP-1 oral meal human .</brief_summary>
	<brief_title>GLP-1 - Regulatory Mechanism Postprandial Glycemia</brief_title>
	<detailed_description>Two experiment perform random order 12 healthy subject . After 50-min basal period subject ingest 412 kcal mixed semisolid meal contain 30g oatmeal , label 99mTc-Sn-colloid . Gastric empty measure high-resolution scintigraphy 210 min meal ingestion . Saline ( SAL ) Ex ( 9-39 ) 900 pmol/kg/min intravenously infuse two experiment . In addition , 6 12 subject gastric motility measure antroduodenal manometry gastric barostat . AUC : pp incremental area curve . Lag period ( LP ) : time 10 % emptying .</detailed_description>
	<criteria>Healthy subject &gt; =18 year age No medication Acute disease Metabolic disease On medication Pregnancy , breast feed Gastrointestinal surgery Dyspeptische Symptome ( Völlegefühl , Blähungen , abdominelle Schmerzereignisse , Übelkeit , Erbrechen , Sodbrennen ) Teilnahme einer klinischen Studie den vergangenen 6 Monaten</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>GLP-1</keyword>
	<keyword>exendin ( 9-39 )</keyword>
	<keyword>gastric empty</keyword>
	<keyword>incretin</keyword>
	<keyword>human</keyword>
</DOC>